Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Form 8.3 - Learning Technologies Group plc - Octopus Investments
-
ARCPOINT ANNOUNCES C$800,000 NON-BROKERED PRIVATE PLACEMENT
-
Ocean Power Technologies Secures $2 Million in Purchase Orders for PowerBuoys® in Latin America
-
Vow ASA: NOK 500 million newbuild contract confirmed
-
Trainday and ZenGen Partner to Digitize Education in Romania with AI-Powered Learning
-
Outlook Therapeutics® Appoints Faisal G. Sukhtian as Chairman of the Board of Directors
-
Fractyl Health Announces Increased Focus on Groundbreaking Revita® Weight Maintenance and Rejuva® Pancreatic Gene Therapy Programs with Potential to Deliver Key Clinical Milestones Across Multiple S
-
Greif, Inc. Announces 2025 First Quarter Earnings Release and Conference Call Dates
-
Garrett Motion Announces Term Loan and Revolving Credit Facility Refinancing and Extension
-
Erasca to Present at the Guggenheim Securities SMID Cap Biotech Conference
-
CervoMed Provides Update on Neflamapimod DLB Program as Part of Presentation at the 8th International Lewy Body Dementia Conference
-
NV5 and U.S. Geological Survey Release High Resolution Lidar Data of Palisades Fire and Eaton Fire Burn Areas to the Public
-
Retrieve Medical Expands into Ambulatory Care with New Client Engagement
-
Genius Group announces issuance and trading of rights in its rights offering.
-
Celebrating 40 Years of the Nasdaq-100 Index® (NDX®)
-
Star Group, L.P. to Host Fiscal 2025 First Quarter Webcast and Conference Call February 6, 2025
-
SeaStar Medical Announces $6 Million Registered Direct Offering Priced At-the-Market
-
LiveOne (Nasdaq: LVO) to Present Business Update at Trump Mar-O-Lago Today
-
Foremost Clean Energy and Rio Grande Resources Announce Completion of Spin-Out Transaction
-
PLBY Group Converts 25% of Preferred Shares to Common at $1.85 Per Share
-
Apollo to Provide USD $500 Million Hybrid Capital Solution to Aldar in Fourth Transaction
-
First Hawaiian, Inc. Reports Fourth Quarter 2024 Financial Results and Declares Dividend
-
Oatly Announces Plan to Implement ADR Ratio Change
-
Iterum Therapeutics to Report Fourth Quarter and Full Year 2024 Financial Results on February 7, 2025
-
Immutep Quarterly Activities Report Q2 FY25
-
Gentex Reports Fourth Quarter and Year End 2024 Financial Results
-
NewGen Announces Reverse Stock Split
-
Former Securitize Capital CEO Wilfred Daye Joins Mercurity Fintech as Chief Strategy Officer and Chaince Securities CEO
-
Rezolute to Participate in the Guggenheim SMID Cap Biotech Conference
-
Proposals of Fingrid’s Shareholders’ Nomination Board to the Annual General Meeting 2025
-
Reminder: Program for the publication of Yara International ASA fourth quarter results 2024
-
Invesco Ltd: Form 8.3 - Direct Line Insurance Group PLC; Public dealing disclosure
-
Invesco Ltd: Form 8.3 - International Paper Co; Public dealing disclosure
-
Topicus.com Inc. acquires 9.99% Stake in Asseco Poland S.A. in Poland
-
Correction: On the resignation of Ignitis Renewables’ CEO
-
Invesco Ltd: Form 8.3 - Loungers PLC; Public dealing disclosure
-
Invesco Ltd: Form 8.3 - Aviva PLC; Public dealing disclosure
-
Dundee Precious Metals Files Technical Report on the Čoka Rakita Gold Project
-
Giyani Progresses to Production Ramp-Up at the Demonstration Plant
-
Y-mAbs Presents Translational Pharmacokinetics of GD2-SADA from Pretargeted RIT Platform at the SNMMI Mid-Winter and ACNM Annual Meeting
-
23andMe Launches New Genetic Report on Osteoporosis
-
Quipt Home Medical Responds to Kanen Wealth Management
-
Dentsu Partners with Adobe to Introduce Adobe GenStudio dentsu+
-
Orrstown Financial Services, Inc. Reports Fourth Quarter 2024 Results
-
POET Engaged by Global Financial Services Leader to Develop Custom Optical Engine
-
Prospect Capital Corporation Makes $65 Million Investment in Taos Footwear
-
BitFuFu to Participate in the 37th Annual ROTH Conference
-
OKYO Pharma Announces Chairman and CEO Acquire Shares
-
Bitfarms Engages Strategic Partners to Develop HPC/AI Business
-
Axsome Therapeutics Hosts SYMBRAVO® FDA Approval Virtual Investor Event with Expert Thought Leader
